Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Short Sellers Are Making Bigger Bets Against Teva and Allergan Stock | Barron's
Three health-care deals today are paying huge premiums - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
How the price action of Teva Pharmaceutical (TEVA) is used to our Advantage - MarketWatch
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock Could Double | Barron's
Teva Stock Is Falling as an Analyst Says It Needs 'Numerous Litigation Wins' | Barron's
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva Stock Could Reach $100 | Barron's
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva Pharmaceutical to Cut 14,000 Jobs - WSJ
Teva shares surge on corporate shake-up - MarketWatch
Investors wary of Teva-Mylan merger - MarketWatch
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
Israel stocks rise, led by Teva, ICL - MarketWatch
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
Teva's Battered Stock Looks Extremely Cheap | Barron's
